Abstract:Dengue is a major public health concern, affecting almost 400 million people worldwide, with about 70% of the global burden of disease in Asia. Despite revised clinical classifications of dengue infections by the World Health Organization, the wide spectrum of the manifestations of dengue illness continues to pose challenges in diagnosis and patient management for clinicians. When the Zika epidemic spread through the American continent and then later to Africa and Asia in 2015, researchers compared the characteristics of the Zika infection to Dengue, considering both these viruses were transmitted primarily through the same vector, the Aedes aegypti female mosquitoes. An important difference to note, however, was that the Zika epidemic diffused in a shorter time span compared to the persisting feature of Dengue infections, which is endemic in many Asian countries. As the pathogenesis of viral illnesses is affected by host immune responses, various immune modulators have been proposed as biomarkers to predict the risk of the disease progression to a severe form, at a much earlier stage of the illness. However, the findings for most biomarkers are highly discrepant between studies. Meanwhile, the cross-reactivity of CD8+ and CD4+ T cells response to Dengue and Zika viruses provide important clues for further development of potential treatments. This review discusses similarities between Dengue and Zika infections, comparing their disease transmissions and vectors involved, and both the innate and adaptive immune responses in these infections. Consideration of the genetic identity of both the Dengue and Zika flaviviruses as well as the cross-reactivity of relevant T cells along with the actions of CD4+ cytotoxic cells in these infections are also presented. Finally, a summary of the immune biomarkers that have been reported for dengue and Zika viral infections are discussed which may be useful indicators for future anti-viral targets or predictors for disease severity. Together, this information appraises the current understanding of both Zika and Dengue infections, providing insights for future vaccine design approaches against both viruses.

DENV and ZIKV infection: Species specificity and broad cell tropism

Understanding the Tissue Specificity of ZIKV Infection in Various Animal Models for Vaccine Development

An Integrated Systems Biology Approach Identifies the Proteasome as A Critical Host Machinery for ZIKV and DENV Replication

Emerging mosquito-borne flaviviruses

Monocyte-Derived Dendritic Cells as Model to Evaluate Species Tropism of Mosquito-Borne Flaviviruses

Defeat Dengue and Zika Viruses With a One-Two Punch of Vaccine and Vector Blockade

Zika and Dengue Viruses Differentially Modulate Host mRNA Processing Factors Defining Its Virulence

Advances in Zika Virus–Host Cell Interaction: Current Knowledge and Future Perspectives

Hide and Seek: The Interplay Between Zika Virus and the Host Immune Response

Syncytial and Congregative Effects of Dengue and Zika Viruses on the Aedes Albopictus Cell Line Differ among the Viral Strains

From Mosquito Bites to Sexual Transmission: Evaluating Mouse Models of Zika Virus Infection

Host immune response against DENV and ZIKV infections

Clustered rapid induction of apoptosis limits ZIKV and DENV-2 proliferation in the midguts of Aedes aegypti

Zika virus reservoirs: Implications for transmission, future outbreaks, drug and vaccine development

Targeting Type I Interferon Induction and Signaling: How Zika Virus Escapes from Host Innate Immunity

Efficiencies and kinetics of infection in different cell types/lines by African and Asian strains of Zika virus

Progress and challenges in development of animal models for dengue virus infection

Sertoli Cells Are Susceptible to ZIKV Infection in Mouse Testis

Tropism of the Chikungunya Virus

A Zika virus mutation enhances transmission potential and confers escape from protective dengue virus immunity

Uncovering Flavivirus Host Dependency Factors through a Genome-Wide Gain-of-Function Screen